Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Harpoon Therapeutics (HARP)

Harpoon Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HARP
DateTimeSourceHeadlineSymbolCompany
11/03/202421:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:55Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:51Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:49Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:40Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:37Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:36Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202413:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HARPHarpoon Therapeutics Inc
11/03/202412:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
08/03/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
28/02/202412:37Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
28/02/202412:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
22/02/202413:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
22/02/202413:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
08/02/202412:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:HARPHarpoon Therapeutics Inc
06/02/202421:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HARPHarpoon Therapeutics Inc
29/01/202421:52Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:HARPHarpoon Therapeutics Inc
29/01/202421:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
10/01/202420:07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:HARPHarpoon Therapeutics Inc
09/01/202411:12IH Market NewsWall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and MoreNASDAQ:HARPHarpoon Therapeutics Inc
08/01/202422:20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
08/01/202422:16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
08/01/202413:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HARPHarpoon Therapeutics Inc
08/01/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HARPHarpoon Therapeutics Inc
08/01/202412:30Business WireMerck to Acquire Harpoon Therapeutics, Further Diversifying Oncology PipelineNASDAQ:HARPHarpoon Therapeutics Inc
05/01/202422:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HARPHarpoon Therapeutics Inc
26/12/202312:30GlobeNewswire Inc.Harpoon Therapeutics Strengthens Leadership TeamNASDAQ:HARPHarpoon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:HARP